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ROTH, K. A. AND R. J. KATZ. Further studies on a novel animal model of depression: Therapeutic effects of a tricyclic 
antidepressant. NEUROSCI. BIOBEHAV. REV. 5(2) 253-258, 1981.--We have previously shown that rats given stress 
before open field testing have elevated activity in comparison with unstressed rats. This acute behavioral response may be 
eliminated by chronic stress and restored by pretreatment with the monoamine oxidase inhibitor pargyline. The present 
study replicated previous findings upon the effects of acute and chronic stress and extended results upon treatment to the 
class of tricyclic antidepressant drugs, using imipramine as a prototypic tricyclic antidepressant. Imipramine also restored 
both behavioral and psychoendocrine activity which was otherwise altered by chronic stress. 
Activity Ambulation Defecation Depression Imipramine Open field 
IN previous reports we have argued that the development of  
novel preclinical models of depression remains an important 
task in the eventual understanding of  clinical disorders [5]. 
We also have described a novel procedure by which a state 
of  relative behavioral depression may be induced in the rat 
[6,7]. The model is similar to learned helplessness 112], be- 
havioral despair  [9], and other models (e.g. [8]). The depres- 
sion model utilizes acute behavioral responses to stress in an 
open field following either chronic stress or control treat- 
ment, and was shown to share both endocrine and psycho- 
pharmacological similarities to endogenous depression. 
Pharmacological similarity was established based upon re- 
versal of  otherwise present depression by the monoamine 
oxidase inhibitor pargyline. A second and more widely em- 
ployed clinical therapy for unipolar depression involves 
tricyclic antidepressants,  and imipramine is a prototypic 
drug of  this class [1,11]. 
The present experiment both replicated selected findings 
from previous studies and extended the range of  compounds 
tested in the stress-depression model to the class of tricy- 
clics. 
METHOD 
Subjects. Sixty-nine adult male Sprague-Dawley rats 
(Charles River Farms, Portage, MI), 70 days on the day of  
testing, were housed 2/cage in 25x 18x 17 cm stainless steel 
cages. Food (Teklad 4.0% fat rodent diet S-0836) and tap 
water were available ad lib for control and experimental 
groups except for three occasions when food or water was 
removed from the experimental groups for 16 hr as part of 
the chronic stress procedure. Lighting cycles of  12 hr/12 hr 
(lights on from 7:00 to 19:00 hr) were automatically pro- 
grammed. Rats were housed as described for 3 weeks prior 
to testing. 
Apparatus. Testing was carried out in a square white 
Plexiglas open field each side of  which was 1.22 m and the 
height of  which was 45 cm. The apparatus was divided into 
16 equal shares 30.5 cm/side to allow for the assessment of 
locomotion. The open field was thoroughly cleaned between 
tests. 
Behavioral procedure. A partial factorial design was 
utilized for open field testing. The first factor was presence 
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or absence of an immediately antecedent noise-light stress. 
This factor was varied across three conditions. A control 
group received no additional manipulations; a second group 
received exposure to a chronic stress procedure (described 
below) and daily injections of  0.9% saline; a third group was 
exposed to the identical stress procedure as group two and 
received daily injections of  the tricyclic antidepressant imip- 
ramine (5 mg/kg/day) for 15 days. Additional rats from each 
group were sacrificed without exposure to the open field to 
obtain basal corticosterone levels. An explicit control for the 
effects of imipramine upon acute stress was not included. 
It should be noted this clearly represents a critical com- 
parison, and that antidepressants do not generally facilitate 
the behavioral effects of  acute noise stress. Because the 
issue is important and to allow an adequate comparative in- 
vestigation a separate set of studies (to be subsequently re- 
ported) upon acute stress interactions was carded out. 
First Factor: Acute Stress Procedure 
Animals were habituated to the presence of an experi- 
menter during the dark cycle. During the week prior to test- 
ing, laboratory personnel entered the housing room and per- 
formed routine tasks at the time when testing was to be later 
carded out (between 2100 and 2400 hr). 
On the test day both subjects in a cage were removed and 
placed individually in 48x27x20 cm polypropylene cages 
(Scientific Products Series 140) for transport.  One rat was 
immediately taken 6 m down an unlit corridor to the test 
room and placed in the open field for testing. The second rat 
was taken a similar distance to a brightly lit room (8x70 W 
lamps) and placed 1 m from a speaker emitting a 95 dB white 
noise. After one hour exposure to the noise-light stress, the 
acutely stressed rat was transported to the test room and 
placed in the open field for testing. 
Second Factor: Chronic Stress Procedure 
Thirteen stressors were administered over a fifteen day 
period. Stressors and times of  delivery were varied so as to 
maximize the unpredictable nature of  the stress procedure.  
The following stressors were used: switch cage mates (two 
times), 24 hr isolation, 30 rain o f  unpredictable shock (one 
1.0 mA shock/60 sec) (two times), 16 hr water deprivation 
(two times), 16 hr food deprivation, 5 rain swim in 4.0°C ice 
water  (two times), 60 rain of  horizontal shaker (two times), 
and I rain tail pinch. These were administered every day to 
two days throughout the lighting cycle (0600 to 1900). Table 1 
presents the schedules of  stress delivery. 
Testing Procedure 
For all subjects the test room was illuminated by six GE 
F96712R fluorescent lights which provided dim (500 mphot) 
red light (600-700 rim) that was subliminal for the subjects 
but allowed experimental observation. A continuous back- 
ground masking noise of  40-50 dB was provided by normal 
operation of  the air circulation system. 
Subjects were placed in a comer  of  the open field facing 
the apparatus wall and a twelve minute observation period 
was automatically timed. The test interval was extended in 
comparison with the previous experiment due to reduced 
availability of  laboratory personnel. In all cases, however,  
the final six minute scores were discarded to allow compari- 
son with previous data and the experiments to be subse- 




1 ea r  m a r k  
2 shaker stress (high speed 1 hr) 
3 cold swim (4°C--5 min) 
4 switch cage mates 
5 shock (1/2 hr) 
6 remove water (16 hr) 
7 tail pinch 
8 remove food (16 hr) 
9 shock (1/2 hr) 
I0 remove water (16 hr) 
11 individual housing (24 hr) 
12 cold swim 
13 shaker stress 
14 switch cage mates 
15 test 
minutes were taken as the primary datum. Again, this was 
done to allow comparison with previous studies from our and 
other laboratories. The following measures were recorded: 
defecation score (boluses/session), latency to initial defeca- 
tion (in sec), latency to leave home square (in sec), outside 
squares crossed (in 3 rain), inside square crossed, and 
number of  rears (in 6 rain). At  the end of  testing, subjects 
were immediately removed,  sacrificed by decapitation, and 
trunk blood was collected in heparinized tubes. Following 
centrifugation at 2400 rpm for 30 rain, plasma was collected 
and frozen at -400C for later corticosterone determination, 
using the method of  Murphy [10]. All determinations were 
performed in duplicate using rat cort icosterone as the assay 
standard. The coefficient of  within assay variation was less 
than 5%, and did not exceed 8% across assays. 
In addition to direct behavioral measures (described 
above) a derived composite measure of  activation was calcu- 
lated based upon an average of  ranks across categories. 
Groups were rank ordered from lowest (1) to highest (6) on 
all measures except  on initial latency to leave home square 
and defecation score, for which reverse orders were used. A 
mean score (average across measures) was then computed 
for each group across ranks. 
RESULTS 
Acute stress increased a number of  motor behaviors and 
decreased defecation in comparison with controls. Chronic 
stress plus vehicle treatment eliminated the behavioral ac- 
tivation seen in control rats after acute noise-light stress. 
Treatment of  chronically stressed rats with imipramine re- 
stored the acute activation response to the noise-light stress. 
These findings were confirmed statistically, and are pre- 
sented in Figs. 1 through 7. Figure 1 presents data based 
upon outside squares crossed (0-3 minutes). There were 
significant differences across categories, F(5,42)=3.5, 
p <0.01. Of interest are the following significant differences: 
(p<0.05 in all cases by Scheffe 's  test: this criterion is used 
throughout). Acute stress elevated initial activity in com- 
parison to an unstressed control; the chronic stress saline 
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FIG. 1. Effects of acute and chronic stress and imipramine upon 
open field activity in the rat (mean outside squares/3 min+SEM). 
B=basal, A-acute stress, C--chronic stress, I=chronic imipramine 
pretreatment (5 mg/kg/day). For all cases the leftmost of the two 
columns displays basal (i.e., no acute stress) activity and the right- 
most shows behavioral response to acute stress. Scores reflect grid 
crossings of animals upon initial exposure to an open field. 
group did not show an elevation in activity after acute stress; 
drug treatment apparently reversed this loss of response to 
acute stress. The imipramine treated chronically stressed 
group receiving acute stress was not reliably different from 
the nonchronic (i.e., control) group after similar treatment. 
This general pattern supports the postulated model and was 
confirmed by other measures. 
Latency to leave home square scores reflected an overall 
change, F(5,42)=2.62, p<0.05 (Fig. 2). This was due to re- 
ductions brought about by acute stress across conditions. 
Again the acutely stressed group moved more quickly than 
its control; the chronically stressed saline group showed a 
marginally significant activation compared to its unstressed 
control (p <0.09). Due to a higher baseline imipramine treat- 
ment restored the acute activation response compared to its 
unstressed control, but not significantly. It must be empha- 
sized that the latency measure did not reflect major altera- 
tions brought about by chronic stress. 
Center field penetration followed a similar course (Fig. 3). 
However, the difference between groups was not statisti- 
cally significant, F(5,42)= 1.4, p =0.3. Further analysis was 
therefore precluded. 
Rearing scores are presented in Fig. 4. An overall effect 
of groups was observed, F(5,42)=3.4, p<0.01. However the 
only significant increase in comparison with a basal (i.e., 
nonacutely stressed control was in nonchronically stressed 
rats, F=4.8;  p<0.03. No acute elevation was seen in chroni- 
cally stressed rats without imipramine, nor was an effect 
seen in the imipramine treated animals, rather the drug ap- 
peared nonspecifically excitatory. 
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FIG. 2. Latency to initial motor activity in an open field after acute 
and chronic stress and imipramine (mean sec+SEM). Figure legend 
presented in Fig. 1. 
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FIG. 3. Center field penetration in an open field in the rat. Effects of 
acute and chronic stress and imipramine (mean+SEM). Figure 
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FIG. 4. Effects of acute and chronic stress and imipramine upon 
rearing activity in an open field (mean+SEM). Figure legend pre- 
sented in Fig. 1. 
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FIG. 5. Defecation score (mean bolus+SEM) in an open field. Ef- 
fects of acute and chronic stress and imipramine. Figure legend in 
Fig. I. 












B - B  B - A  C - B  C - A  C I - B  C I - A  
FIG. 6. Defecation score (latency to initial defecation) in an open 
field (mean sec + SEM). Effects of acute and chronic stress and imip- 
famine. Figure legend in Fig. I. 
those seen in motor activation. There was an overall groups' 
effect, F(5,42)=5.1, p<0.001. Chronic stress increased defe- 
cation in the unstressed condition; in the acutely stressed 
groups, the saline treated chronic stress group defecated 
more than controls and this was reversed by imipramine 
treatment. The imipramine treated group showed a signifi- 
cant decrease in defecation between unstressed and acutely 
stressed conditions. 
A further measure of defecation (latency; Fig. 6) followed 
a converse course. There was an overall significant groups 
effect, F(5,42)=4.0, p<0.005. Chronic stress lowered the la- 
tency to defecation in the unstressed groups but only the 
saline treated chronically stressed group was significantly 
lower than controls in the acute stressed condition. 
Results for plasma corticosterone are presented in Fig. 7. 
Groups differed overall from each other, F(8,60)=10.4, 
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FIG. 7. Endocrine activity in response to acute and chronic stress, 
imipramine, and open field testing. Mean plasma conicosterone 
value in /~g/dl+SEM. NO OF=never exposed to open field: OF 
B=basal open field exposure prior to sacrifice; OF A=exposed to l 
hr noise stress and open field prior to sacrifice. B=basal (no chronic 
stress); C=exposed to chronic stress regimen; I=exposed to both 
chronic stress and concurrent imipramine. 
rone due to open field testing, a marginal ¢o<0.06) further 
increase due to stress prior to the open field, a significant 
increase in corticosterone in stressed subjects vs basal sub- 
jects (i.e., open field groups), and a significant imipramine 
induced reduction in plasma corticosterone in the chroni- 
cally stressed groups. It must be noted that a slight nonsig- 
nificant decrease in corticosterone was present after chronic 
stress in those rats which were not behaviorally tested. 
Figure 8 confirms the above findings based upon the 
summary measure. The overall effect was significant, 
F(5,35)=4.1, p<0.005. Post hoc comparisons coniru'med the 
major findings that acute stress produced behavioral activa- 
tion, a loss of stress induced activation by chronic stress, 
and a restoration of acute stress responding after imipramine 
treatment. 
DISCUSSION 
One question inherent in the development of preclinical 
procedures concerns the systematic validity of a given 
model. While explicit criteria exist for evaluating laboratory 
models, they are often utilized selectively or inconsistently. 
At the very least, however, a commonality of behavioral 
phcnomenology (depressive behavior upon the part of the 
animal), physiology (the existence of similar indicators of a 
central disorder insofar as preexisting physiological differ- 
ences allow comparison) and of pharmacological response 
must be addressed by the serious researcher. The present 
study presents both behavioral and physiological evidence 
which conf'a'm a previous report [5] and also suggest that 
therapeutic response is not limited to inhibitors of 
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FIG. 8. Summary measure of overall activity based upon mean rank 
across categories. For a detailed description of the measure and its 
computation see text (Method). Figure legend as in Fig. 1. 
monoamine oxidase,  but may be present with tricyclic 
antidepressants.  This response is probably not limited to 
drug classes thought to act via their noradrenergic effects, 
since other tricyclics (e.g., amitriptyline) and tetracyclics 
(e.g., mianserine) are equally effective. 
Acute stress induced alterations in activity were seen in 
five categories of  behavior (activity, latency, center field ac- 
tivity, defecation scores). The acute stress effect was clearly 
blunted by a history of antecedent stress, and restored by 
drug treatment. Antidepressants such as imipramine 
produced no consistent effects upon the acute stress re- 
sponse in rats not exposed to chronic stress procedures.  
Within limits, concomitant psychoendocrine measures 
further suggest similarities to clinical disorders. A number of 
pituitary-adrenal response comparisons were marginally 
significant. This must be understood, however, as being due 
in part to a more protracted testing interval than previously 
employed. Open field exposure is mildly stressful, and there- 
fore may have reduced effects due to an overall increase in 
baseline endocrine activity. 
Perhaps the most puzzling aspect of  the endocrine data is 
the apparent absence of  a hypersecretion of  corticosterone in 
chronically stressed but behaviorally naive rats. This may 
point to a potential difference from clinical pathophysiology. 
On the other hand open field tested rats did show a typical 
basal hypersecretion and may in fact embody a greater simi- 
larity to typical clinical conditions then behaviorally naive 
unstressed rats. When psychoendocrine studies are carried 
out clinically the presence of  additional staff and the drawing 
of  blood may both be novel and mildly stressful, as is the 
open field for the rat. Finally, Carroll [2] has reported no 
effect of acute stress on plasma cortisol in human de- 
pressives. This may be related to the acute stress conditions 
of  the present design (rightmost three columns of  Fig. 7) 
which may be seen to not show an effect of  chronic stress. 
It is of particular interest that in the present study imip- 
ramine, a drug with established psychomotor  inhibitory 
properties (e.g. [4,8]; also the present study) nonetheless 
restored a stress induced activation deficit. Clearly this can- 
not be regarded as a mere summation of  behavioral and 
pharmacological excitation, since the drug itself is normally 
inhibitory. This finding suggests that the facilitatory effect is 
highly specific and dependent upon the prior existence of  
behavioral depression. 
The precise mechanisms underlying these effects remain 
to be identified. Some effects, particularly defecation, may 
be due to the effects of  imipramine upon gastric motility, al- 
though it is not clear this explanation also accounts for other 
behavioral effects, the consistency seen across behaviors,  or 
the general consistency across drug categories. Another  
possibility rests with the notion of  "s t ress  tolerance."  Weiss 
and co-workers have reported some reduction of  acute 
stress-responsiveness after a history of  stress [12]. Although 
stress modality and chronic stress procedures differ, it is 
possible that the same or analogous processes are involved 
in the present behavioral reductions. The present study ex- 
tends previous studies upon a novel animal model of  depres- 
sion, and suggests a useful procedure for further examining 
questions of clinical interest. 
ACKNOWLEDGEMENTS 
Supported by grant MH31588 to Dr. B. J. Carroll (with Dr. Katz 
as co-investigator). Statistical assistance of Bob Shea and technical 
assistance of Pare Olton are acknowledged with gratitude. Dr. Katz 
currently is a Sloan Research Foundation Fellow in Neuroscience, 
Kevin Roth currently is a predoctoral fellow within the laboratory of 
Dr. J. Barchas. Correspondence to the second author. 
REFERENCES 
1. Beck, A. T. Depression. Clinical Experimental and Theoretical 
Aspects. New York: Hoerber Med. Div. Harper and Row, 1967. 
2. Carroll, B. J. Studies with hypothalamic pituitary adrenal stimu- 
lation tests in depression. In: Depressive Illness Some Research 
Studies, edited by B. M. Davies, B. J. Carroll and R. M. Mow- 
bray. Springfield, I11.: Charles C. Thomas Publisher. 1972, pp. 
149--201. 
3. Dixon, W. J. and F. J. Massey. Introduction to Statistical 
Analysis. New York: McGraw Hill, 1969. 
4. Furgiuele, A. R., M. H. Aumente and Z. P. Horovitz. Acute and 
chronic effects of imipramine and desipramine in normal rats 
and in rats with lesioned amygdalae. Archs int. Pharmacodyn. 
151: 129, 1964. 
5. Katz, R. J. Animal models and human depressive disorders. 
Neurosei. Biobehav. Rev. 5: 231-246, 1981. 
6. Katz, R. J., K. A. Roth and B. J. Carroll. Acute and chronic 
stress effects on open field activity in the rat: Implications for a 
model of depression. Neurosci. Biobehav. Rev. 5: 247-251, 
1981. 
258 R O T H  A N D  K A T Z  
7. Katz, R. J. and S. Hirsch. Amitriptyline and scopolamine in an 
animal model of depression. Neurosci. Biobehav. Rev. 5: 265- 
271, 1981. 
8. Garzon, J., J. A. Fuentes and J. Delrio. Antidepressants selec- 
tively antagonize the hyperactivity induced in rats by long term 
isolation. Eur. J. Pharmac. 593: 93-296, 1979. 
9. Porsolt, R. D., G. Anon,  N. Biaret, M. Daniel and M. Jalfre. 
Behavioral despair in rats, a new model sensitive to 
antidepressant treatments. Eur. J. Pharmac. 47: 379-391, 1978. 
10. Murphy, B. E. P. Some studies of the protein binding of steroids 
and their application to the routine micro and ultramicro meas- 
urement of various steroids in body fluids by competitive 
protein-binding radioassay. J. clin. Endocr. 27: 973-990, 1%7. 
11. Von Praag, H. H. Psychotropic Drugs-A Guide for the Practi- 
tioner. New York: Brunner-Mazel, 1978. 
12. Weiss, J. M., H. I. Glaser, L. A. Pohorecky, J. Brick and N. E. 
Miller. Effects of chronic exposure to stressors on avoidance-- 
escape behaviors and on brain-norepinephrine. Psycho.~mn. 
Med. 37: 522-534, 1975. 
